4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000014
Chief Financial Officer sold 2,298 shares at an average $23.83 ($54,757)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barnett Eva Renee Chief Financial Officer | 2025-01-15 | Sale | −2,189 | $23.81 | $52,120 | 324,875 | D |
| Barnett Eva Renee Chief Financial Officer | 2025-01-15 | Sale | −109 | $24.19 | $2,637 | 324,766 | D |
| Open-market sales · 2,298 sh · avg $23.83 · $54,757 | |||||||
Loading xslF345X05/wk-form4_1737147952.xml…